comparemela.com
  1. Home
  2. Live Updates
  3. Interchangeable Biosimilars - Breaking News

Latest Breaking News On - Interchangeable biosimilars - Page 2 : comparemela.com

Challenges Payers Face With Biosimilars

Kimberly C. Chen DO, MSHLM, and Maia Kayal, MD, MS, review the challenges related to biosimilars from the payer perspective and strategies payers may employ to help improve the uptake of biosimilars.

Maia kayalKimberlyc chenBiosimilars stakeholder summitInterchangeable biosimilarsInflammatory diseasesChallenges with biosimilarsPayer perspectiveImprove biosimilar uptakeBiosimilar extrapolationReduced approval timeMultiple indicationsReference productFda approval process

Barriers to Biologics Access

Jonathan Kay, MD, reviews the barriers related to access of biologics such as economic barriers, health inequities, or disparities.

Jonathan kayBiosimilars stakeholder summitInterchangeable biosimilarsInflammatory diseases

Savings Potential With Biosimilars

Jonathan Kay, MD, and Kimberly C. Chen DO, MSHLM, define what a biosimilar is and discuss the potential for a lower cost than the reference product.

Jonathan kayKimberlyc chenBiosimilars stakeholder summitInterchangeable biosimilarsInflammatory diseasesReference productLower costClinical trial

Cost Drivers Contributing to the Economic Impact of Inflammatory Diseases

A panel of experts review the key drivers contributing to the economic impact of inflammatory diseases in the United States.

United statesBiosimilars stakeholder summitInterchangeable biosimilarsInflammatory diseasesDrivers contributingEconomic impact

Biologics Used in Inflammatory Diseases

Maia Kayal, MD, MS, provides an overview of the biologics used in inflammatory diseases.

Maia kayalBiosimilars stakeholder summitInterchangeable biosimilarsInflammatory diseases

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.